News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages Todd Neale November 06, 2025
News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity L.A. McKeown December 23, 2024
News Daily News Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea Michael O'Riordan June 25, 2024
News Daily News Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea Michael O'Riordan June 21, 2024
News Daily News Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity Todd Neale April 17, 2024
News Conference News ACC 2024 Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT Caitlin E. Cox April 06, 2024
News Daily News Adherence Key to CPAP’s Benefits in Sleep Apnea Patients With CVD Caitlin E. Cox October 04, 2023
News Daily News Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS Michael O'Riordan December 30, 2022
News Daily News From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF Caitlin E. Cox October 27, 2022
News Daily News Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA L.A. McKeown June 23, 2021
News Conference News ESC 2020 Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism Caitlin E. Cox September 04, 2020
News Daily News Higher Risk of Atrial Fibrillation in Retired Football Players Michael O'Riordan July 25, 2019